|
|
Blood test may identify smokers at high risk of heart disease
A simple blood test may one day measure the toxicity of the lung and heart disease risk in smokers, said researchers at the University Medical Center in Texas.
A simple blood test may one day measure the toxicity of the lung and heart disease risk in smokers, said researchers at the University Medical Center in Texas.
Nearly one out of every five adults in the United States are smokers, and smoking-related medical expenses and lost productivity exceed $ 167 billion annually, according to the Centers for control and prevention of diseases.
"The levels of protein in the blood of the lung in smokers can refer to the risk of accumulation of plaque in blood vessels," said Dr. Anand Rotagy, assistant professor of internal medicine at the University of Texas and co-led the study available in the hardening of the arteries, clots, and publications the American Heart Association .
And also added "We are now close to a blood test that helps measure the effects associated with smoking, which contributes to heart disease and hardening of the arteries" and smoking is one of the most factors in the development of heart disease.
Smokers are at increased risk of heart attack, stroke and death due to heart disease, but the risk varies between individuals. Until this study, there was no simple blood test to measure the various effects of smoking on heart disease.
Researchers have identified the quantity and presence of pulmonary surfactant B (pulmonary surfactant B), a protein found in lung cells damaged in more than 3200 of the participants in the study of Dallas for the heart and between the ages of 30-65 years, and the study of the Dallas Heart foundation stone for examination heart disease and blood vessels, through the provision of blood samples and examination of vascular magnetic resonance imaging and computed tomography.
The researchers found that smokers who have higher levels of pulmonary surfactant B (pulmonary surfactant B), as they were more dangerous to the accumulation of plaque in the aorta - the largest artery in the body, its branches in the pelvis, abdomen and legs.
And the test is still under evaluation and is not available for commercial use now. The next step, said Dr. Anand Rotagy, is to check whether the pulmonary surfactant B causes hardening of the arteries or is just a sign of the disease, and to determine whether low levels of pulmonary surfactant B will improve the results of heart disease.
"The levels of protein in the blood of the lung in smokers can refer to the risk of accumulation of plaque in blood vessels," said Dr. Anand Rotagy, assistant professor of internal medicine at the University of Texas and co-led the study available in the hardening of the arteries, clots, and publications the American Heart Association .
And also added "We are now close to a blood test that helps measure the effects associated with smoking, which contributes to heart disease and hardening of the arteries" and smoking is one of the most factors in the development of heart disease.
Smokers are at increased risk of heart attack, stroke and death due to heart disease, but the risk varies between individuals. Until this study, there was no simple blood test to measure the various effects of smoking on heart disease.
Researchers have identified the quantity and presence of pulmonary surfactant B (pulmonary surfactant B), a protein found in lung cells damaged in more than 3200 of the participants in the study of Dallas for the heart and between the ages of 30-65 years, and the study of the Dallas Heart foundation stone for examination heart disease and blood vessels, through the provision of blood samples and examination of vascular magnetic resonance imaging and computed tomography.
The researchers found that smokers who have higher levels of pulmonary surfactant B (pulmonary surfactant B), as they were more dangerous to the accumulation of plaque in the aorta - the largest artery in the body, its branches in the pelvis, abdomen and legs.
And the test is still under evaluation and is not available for commercial use now. The next step, said Dr. Anand Rotagy, is to check whether the pulmonary surfactant B causes hardening of the arteries or is just a sign of the disease, and to determine whether low levels of pulmonary surfactant B will improve the results of heart disease.
0 Comments:
Post a Comment